208 related articles for article (PubMed ID: 22735596)
1. Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer.
Sugihara Y; Taniguchi H; Kushima R; Tsuda H; Kubota D; Ichikawa H; Sakamoto K; Nakamura Y; Tomonaga T; Fujita S; Kondo T
J Proteomics; 2012 Sep; 75(17):5342-55. PubMed ID: 22735596
[TBL] [Abstract][Full Text] [Related]
2. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
[TBL] [Abstract][Full Text] [Related]
3. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
[TBL] [Abstract][Full Text] [Related]
4. End-binding protein 1 (EB1) up-regulation is an early event in colorectal carcinogenesis.
Stypula-Cyrus Y; Mutyal NN; Dela Cruz M; Kunte DP; Radosevich AJ; Wali R; Roy HK; Backman V
FEBS Lett; 2014 Mar; 588(5):829-35. PubMed ID: 24492008
[TBL] [Abstract][Full Text] [Related]
5. Protein interactions of FAM134B with EB1 and APC/beta-catenin in vitro in colon carcinoma.
Islam F; Chaousis S; Wahab R; Gopalan V; Lam AK
Mol Carcinog; 2018 Nov; 57(11):1480-1491. PubMed ID: 29964340
[TBL] [Abstract][Full Text] [Related]
6. Regulation and function of the interaction between the APC tumour suppressor protein and EB1.
Askham JM; Moncur P; Markham AF; Morrison EE
Oncogene; 2000 Apr; 19(15):1950-8. PubMed ID: 10773885
[TBL] [Abstract][Full Text] [Related]
7. Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology.
Chen D; Chen F; Lu X; Yang X; Xu Z; Pan J; Huang Y; Lin H; Chi P
Int J Oncol; 2010 Aug; 37(2):355-65. PubMed ID: 20596663
[TBL] [Abstract][Full Text] [Related]
8. APC and EB1 function together in mitosis to regulate spindle dynamics and chromosome alignment.
Green RA; Wollman R; Kaplan KB
Mol Biol Cell; 2005 Oct; 16(10):4609-22. PubMed ID: 16030254
[TBL] [Abstract][Full Text] [Related]
9. An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.
Han CL; Chen JS; Chan EC; Wu CP; Yu KH; Chen KT; Tsou CC; Tsai CF; Chien CW; Kuo YB; Lin PY; Yu JS; Hsueh C; Chen MC; Chan CC; Chang YS; Chen YJ
Mol Cell Proteomics; 2011 Apr; 10(4):M110.003087. PubMed ID: 21209152
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression analysis of leucine-rich PPR-motif-containing protein (LRPPRC), a candidate colorectal cancer biomarker identified by shotgun proteomics using iTRAQ.
Nishio T; Kurabe N; Goto-Inoue N; Nakamura T; Sugimura H; Setou M; Maekawa M
Clin Chim Acta; 2017 Aug; 471():276-282. PubMed ID: 28622966
[TBL] [Abstract][Full Text] [Related]
11. EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration.
Wen Y; Eng CH; Schmoranzer J; Cabrera-Poch N; Morris EJ; Chen M; Wallar BJ; Alberts AS; Gundersen GG
Nat Cell Biol; 2004 Sep; 6(9):820-30. PubMed ID: 15311282
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
[TBL] [Abstract][Full Text] [Related]
14. APC binds to the novel protein EB1.
Su LK; Burrell M; Hill DE; Gyuris J; Brent R; Wiltshire R; Trent J; Vogelstein B; Kinzler KW
Cancer Res; 1995 Jul; 55(14):2972-7. PubMed ID: 7606712
[TBL] [Abstract][Full Text] [Related]
15. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
16. Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells.
Zhang Y; Xiao Q; Zhang H; Sun X; Ge H; Liu X; Guan L; Sun M
Oncol Rep; 2014 Apr; 31(4):1811-7. PubMed ID: 24573033
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.
Tan HT; Wu W; Ng YZ; Zhang X; Yan B; Ong CW; Tan S; Salto-Tellez M; Hooi SC; Chung MC
J Proteome Res; 2012 Feb; 11(2):1433-45. PubMed ID: 22181002
[TBL] [Abstract][Full Text] [Related]
18. The APC-EB1 interaction.
Morrison EE
Adv Exp Med Biol; 2009; 656():41-50. PubMed ID: 19928351
[TBL] [Abstract][Full Text] [Related]
19. [Biomarker Discovery of Colorectal Cancer Using Membrane Proteins Extracted from Cancer Tissues].
Tomonaga T; Kume H
Rinsho Byori; 2015 Mar; 63(3):322-7. PubMed ID: 26524855
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
Hu T; Weng S; Tang W; Xue R; Chen S; Cai G; Cai Y; Shen X; Zhang S; Dong L
PLoS One; 2015; 10(5):e0125281. PubMed ID: 25933218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
